Some of this work reached early human investigation: full-length Thymosin Beta-4 has been examined in clinical-stage research for indications such as dry-eye disease and wound healing, which gives TB-500's parent compound a somewhat broader human-research footprint than BPC-157 although the synthetic TB-500 fragment itself remains a research compound without approval
Can you still drink coffee after taking thyroid medication
M., La Marca, R., Erni, K., & Ehlert, U
Retatrutide clinical trials registry
The comparisons that follow use mechanism, clinical or preclinical trial data, dosing conventions, and regulatory status to give clinicians and patients a usable decision framework rather than marketing language